Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Right heart catheterization for pulmonary hypertension during the coronavirus disease 2019 pandemic.

Literature DB >> 32983409

Right heart catheterization for pulmonary hypertension during the coronavirus disease 2019 pandemic.

Kanza N Qaiser¹, James E Lane², Adriano R Tonelli³.

Abstract

Right heart catheterization is an essential diagnostic modality in the evaluation of pulmonary hypertension. The coronavirus disease 2019 pandemic has resulted in deferral of elective procedures including right heart catheterization. The benefits of proceeding with right heart catheterization, such as further characterization of hemodynamic subtype and severity of pulmonary hypertension, initiation of targeted pulmonary arterial hypertension therapy, as well as further hemodynamic testing, need to be carefully balanced with the risk of potentially exposing both patients and health care personnel to coronavirus disease 2019 infection. This review article aims to provide best clinical practices for safely performing right heart catheterization in pulmonary hypertension patients during the coronavirus disease 2019 pandemic.

Entities: Disease Species

Keywords: COVID-19; coronavirus; infection prevention; pulmonary hypertension; right heart catheterization

Year: 2020 PMID： 32983409 PMCID： PMC7498971 DOI： 10.1177/2045894020948783

Source DB: PubMed Journal: Pulm Circ ISSN： 2045-8932 Impact factor: 3.017

41 in total

1. Interpreting a covid-19 test result.

Authors: Jessica Watson; Penny F Whiting; John E Brush
Journal: BMJ Date: 2020-05-12

2. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis.

Authors: A Vieillard-Baron; J M Schmitt; R Augarde; J L Fellahi; S Prin; B Page; A Beauchet; F Jardin
Journal: Crit Care Med Date: 2001-08 Impact factor: 7.598

3. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.

Authors: Emil L Fosbøl; Jawad H Butt; Lauge Østergaard; Charlotte Andersson; Christian Selmer; Kristian Kragholm; Morten Schou; Matthew Phelps; Gunnar H Gislason; Thomas A Gerds; Christian Torp-Pedersen; Lars Køber
Journal: JAMA Date: 2020-07-14 Impact factor: 56.272

4. Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry.

Authors: Charles D Burger; Pamela K Long; Monarch R Shah; Michael D McGoon; Dave P Miller; Alain J Romero; Wade W Benton; Robert E Safford
Journal: Chest Date: 2014-11 Impact factor: 9.410

Review 5. Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review.

Authors: Daniel P Oran; Eric J Topol
Journal: Ann Intern Med Date: 2020-06-03 Impact factor: 25.391

6. Author rebuttal to response regarding "Letter to the Editor regarding 'Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?'".

Authors: Evelyn Horn; Murali M Chakinala; Ronald Oudiz; Elizabeth Joseloff; Erika B Rosenzweig
Journal: Pulm Circ Date: 2020-06-23 Impact factor: 3.017

1. Evaluating Signs of Pulmonary Hypertension on Computed Tomography and Correlating With Echocardiography: A Study at a Tertiary Care Hospital.

Authors: Abdur Rehman; Jaideep Darira; Muhammad Saad Ahmed; Kamran Hamid; Muhammad Kashif Shazlee; Syed Muhammad Shahnawaz Hyder
Journal: Cureus Date: 2022-05-25

1 in total

Right heart catheterization for pulmonary hypertension during the coronavirus disease 2019 pandemic.

1. Interpreting a covid-19 test result.

2. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis.

3. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.

4. Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry.

Review 5. Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review.

6. Author rebuttal to response regarding "Letter to the Editor regarding 'Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?'".

7. COVID-19 and the pulmonary vasculature.

Review 8. Novel insights on the pulmonary vascular consequences of COVID-19.

9. Natural History of Asymptomatic SARS-CoV-2 Infection.

Review 10. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).

1. Evaluating Signs of Pulmonary Hypertension on Computed Tomography and Correlating With Echocardiography: A Study at a Tertiary Care Hospital.